Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,298
archived clinical trials in
Insomnia Sleep Studies

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Lafayette Hill, PA
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Lafayette Hill, PA
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Warwick, RI
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Warwick, RI
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Anderson, SC
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Anderson, SC
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Austin, TX
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Fairfax, VA
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Fairfax, VA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Glendale, AZ
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Glendale, AZ
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Glendale, CA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Glendale, CA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Hallandale Beach, FL
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Hallandale Beach, FL
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Miami, FL
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Fayetteville, GA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Fayetteville, GA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Hinesville, GA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Hinesville, GA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Suwanee, GA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Suwanee, GA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Crestview Hills, KY
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Crestview Hills, KY
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Baton Rouge, LA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
New Orleans, LA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Newton, MA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Newton, MA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Fayetteville, NC
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Fayetteville, NC
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from
Clamart,
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from
Clamart,
Click here to add this to my saved trials
Use of Armodafinil for Fatigue in Sarcoidosis
Use of Armodafinil (R-modafinil) for Fatigue in Sarcoidosis
Status: Enrolling
Updated:  5/26/2015
University of Cincinnati
mi
from
Cincinnati, OH
Use of Armodafinil for Fatigue in Sarcoidosis
Use of Armodafinil (R-modafinil) for Fatigue in Sarcoidosis
Status: Enrolling
Updated: 5/26/2015
University of Cincinnati
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Brain Energy and Cognition
Brain Energy and Cognition
Status: Enrolling
Updated:  5/29/2015
Usariem
mi
from
Natick, MA
Brain Energy and Cognition
Brain Energy and Cognition
Status: Enrolling
Updated: 5/29/2015
Usariem
mi
from
Natick, MA
Click here to add this to my saved trials
The Impact of Arousal Threshold in Obstructive Sleep Apnea
The Impact of Arousal Threshold in Obstructive Sleep Apnea: Donepezil's Effects on the Arousal Threshold and on the Apnea Hypopnea Index
Status: Enrolling
Updated:  6/4/2015
University of California, San Diego
mi
from
San Diego, CA
The Impact of Arousal Threshold in Obstructive Sleep Apnea
The Impact of Arousal Threshold in Obstructive Sleep Apnea: Donepezil's Effects on the Arousal Threshold and on the Apnea Hypopnea Index
Status: Enrolling
Updated: 6/4/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Status: Enrolling
Updated:  6/22/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Status: Enrolling
Updated: 6/22/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Status: Enrolling
Updated:  7/1/2015
BWH Division of Sleep Medicine
mi
from
Boston, MA
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Status: Enrolling
Updated: 7/1/2015
BWH Division of Sleep Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Study of the Insomnia in Patients With Low Back Pain
Double-blind, Placebo-controlled Study of the Safety and Efficacy of Eszopiclone in the Treatment of Insomnia in Patients With Chronic Low Back Pain
Status: Enrolling
Updated:  7/2/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Study of the Insomnia in Patients With Low Back Pain
Double-blind, Placebo-controlled Study of the Safety and Efficacy of Eszopiclone in the Treatment of Insomnia in Patients With Chronic Low Back Pain
Status: Enrolling
Updated: 7/2/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Study of Sleep and Delirium in the Intensive Care Unit (ICU)
Sleep Disruption and ICU Delirium: Delirium Assessment and Monitoring Combined With the Evaluation of Sleep Using the Sedline Brain Function Monitor.
Status: Enrolling
Updated:  7/13/2015
University of California at San Francisco
mi
from
San Francisco, CA
Study of Sleep and Delirium in the Intensive Care Unit (ICU)
Sleep Disruption and ICU Delirium: Delirium Assessment and Monitoring Combined With the Evaluation of Sleep Using the Sedline Brain Function Monitor.
Status: Enrolling
Updated: 7/13/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
SleepTrackTXT Feasibility and Pilot Study
The Sleep Track Text Pilot Trial in Emergency Care Clinicians
Status: Enrolling
Updated:  7/14/2015
University of Pittsburgh Department of Emergency Medicine School of Medicine
mi
from
Pittsburgh, PA
SleepTrackTXT Feasibility and Pilot Study
The Sleep Track Text Pilot Trial in Emergency Care Clinicians
Status: Enrolling
Updated: 7/14/2015
University of Pittsburgh Department of Emergency Medicine School of Medicine
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Positive Airway Pressure for the Treatment of Asthma
Positive Airway Pressure for the Treatment of Asthma
Status: Enrolling
Updated:  7/20/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Positive Airway Pressure for the Treatment of Asthma
Positive Airway Pressure for the Treatment of Asthma
Status: Enrolling
Updated: 7/20/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated:  7/21/2015
Cleveland Sleep Research Center
mi
from
Middleburg Heights, OH
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated: 7/21/2015
Cleveland Sleep Research Center
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Combination Therapy to Treat Sleep Apnea
Combination Therapy for the Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  7/21/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Combination Therapy to Treat Sleep Apnea
Combination Therapy for the Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 7/21/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Actigraphic Analysis of Treatment Response
Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome
Status: Enrolling
Updated:  7/28/2015
Child Psychopharmacology Institute
mi
from
Fargo, ND
Actigraphic Analysis of Treatment Response
Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome
Status: Enrolling
Updated: 7/28/2015
Child Psychopharmacology Institute
mi
from
Fargo, ND
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
Yale University
mi
from
New Haven, CT
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
University of Indiana
mi
from
Indianapolis, IN
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
University of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
Status: Enrolling
Updated:  8/3/2015
Brigham and Women's Hosp
mi
from
Boston, MA
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
Status: Enrolling
Updated: 8/3/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated:  8/4/2015
University of Rochester, James P. Wilmot Cancer Center
mi
from
Rochester, NY
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated: 8/4/2015
University of Rochester, James P. Wilmot Cancer Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated:  8/4/2015
Behavioral Sleep Medicine Program, Department of Psychiatry, University of Pennsylvania
mi
from
Philadelphia, PA
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated: 8/4/2015
Behavioral Sleep Medicine Program, Department of Psychiatry, University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated:  8/4/2015
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/4/2015
Children's Hospital of The King's Daughters
mi
from
Norfolk, VA
Click here to add this to my saved trials
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  8/4/2015
Duke University
mi
from
Durham, NC
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/4/2015
Duke University
mi
from
Durham, NC
Click here to add this to my saved trials
Acupressure for Persistent Cancer Related Fatigue
Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors
Status: Enrolling
Updated:  8/5/2015
University of Michigan
mi
from
Ann Arbor, MI
Acupressure for Persistent Cancer Related Fatigue
Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors
Status: Enrolling
Updated: 8/5/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
BryanLGH Heart Institute
mi
from
Lincoln, NE
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
BryanLGH Heart Institute
mi
from
Lincoln, NE
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Ohio State University
mi
from
Columbus, OH
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Lancaster Heart and Stroke Foundation
mi
from
Lancaster, PA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
St. Thomas Heart
mi
from
Nashville, TN
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
St. Thomas Heart
mi
from
Nashville, TN
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Sentara Cardiovascular Research Institute
mi
from
Norfolk, VA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Heart and Diabetes Center
mi
from
Bad Oeynhausen,
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Heart and Diabetes Center
mi
from
Bad Oeynhausen,
Click here to add this to my saved trials
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated:  8/10/2015
VA Connecticut Health Care System
mi
from
West Haven, CT
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated: 8/10/2015
VA Connecticut Health Care System
mi
from
West Haven, CT
Click here to add this to my saved trials
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated:  8/10/2015
Richard L. Roudebush VA Medical Center
mi
from
Indianapolis, IN
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated: 8/10/2015
Richard L. Roudebush VA Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study
Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study
Status: Enrolling
Updated:  8/11/2015
Durham VA Medical Center
mi
from
Durham, NC
Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study
Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study
Status: Enrolling
Updated: 8/11/2015
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
Phase IV Study of Bi-Level Positive Positive Airway Pressure (BiPAP)Compared to Nasal Continuous Positive Airway Pressure (CPAP) Therapy
Status: Enrolling
Updated:  8/12/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
Phase IV Study of Bi-Level Positive Positive Airway Pressure (BiPAP)Compared to Nasal Continuous Positive Airway Pressure (CPAP) Therapy
Status: Enrolling
Updated: 8/12/2015
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials